Head-to-head · WeighScore
Sumbare Wellness vs Trillium Meds
The verdict
Trillium Meds takes it — 69.4/100 to 61.9/100.
Trillium Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Trillium Meds is a small, owner-operated telehealth platform based in Portland, OR that connects patients with independent licensed providers and FDA-registered compounding pharmacies for compounded…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Sumbare Wellness | Trillium Meds |
|---|---|---|
| WeighScore | 61.9/100 | 69.4/100 |
| Grade | C | C |
| Scorecard rank | #281 | #124 |
| Semaglutide | $199/mo (all doses, compounded) | $119/mo (3-month plan, compounded) |
| Tirzepatide | $199/mo (all doses, compounded) | $199/mo (3-month plan, compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #281 · C
Strengths
- One flat $199/month price covering medication, provider review and shipping, with no consultation fee and no dose-change surcharge
- Charges nothing if a provider does not approve you
- Offers a deliberate low-dose microdosing protocol aimed at body composition, which most competitors do not break out
- Publishes a named legal entity, a US mailing address and a working phone number
- Pre-screening quiz is short and asks your goal before any medical question
Where it loses points
- Cancellation terms contradict three ways: the homepage says cancel anytime, the Terms say 48 hours notice, the FAQ says 30 days
- Availability is unclear: the homepage counter reads 3 states while the treatment pages say telehealth nationwide, and no state list is published
- Its chart cites placebo-controlled trials of compounded semaglutide and tirzepatide, which do not exist; those trials studied the branded drugs
- No compounding pharmacy is named, and neither 503A nor 503B appears anywhere on the site
- Any returned prescription is charged a $35 disposal fee, and prescription orders cannot be cancelled at all after 24 hours
Graded #124 · C
Strengths
- LegitScript certified with an active seal; serves all 50 states plus Puerto Rico with no geographic restrictions
- All-inclusive pricing covers medication, provider consultation, and shipping with no hidden fees or add-ons
- Two pharmacy options (BPI Labs with B6, ProRx) and three plan structures: 1-month, 3-month fixed, or 3-month titrated
- Small owner-operated; founder personally handles customer support outside business hours for direct, responsive service
- Klarna and Affirm financing available; pause anytime with no long-term commitment required
Where it loses points
- No labs, coaching, or clinical monitoring included — telehealth Rx and pharmacy fulfillment only
- Small single-operator platform may limit capacity and support consistency as patient volume grows
- Compounded medications are not FDA-approved; newer platform with limited long-term public track record
- Tirzepatide from $199/mo (3-mo plan) is mid-market; sema from $119/mo competitive but not lowest available
- No live video consult disclosed; async intake-form-based provider review by external licensed provider network
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.